Atrium Therapeutics, Inc.

RNA

—

Advanced chart & tools →

Atrium Therapeutics, Inc.RNA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.97

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$19.64M

Net income

$-16.63M

Net margin

-84.7%

Gross margin

—

Dividends & financials

Atrium Therapeutics, Inc. (RNA) reported revenue of $19.64M and net income of $-16.63M, or $-0.97 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.